Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

ClinicalTrials.gov ID: NCT03605862

Public ClinicalTrials.gov record NCT03605862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 11:26 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Trial to evaluate efficacy and safety of nitazoxanide in the treatment of colds due to Enterovirus/Rhinovirus infection

Study identification

NCT ID
NCT03605862
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Romark Laboratories L.C.
Industry
Enrollment
1,756 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 11, 2018 (Actual)
Primary completion
Feb 4, 2019 (Actual)
Completion
Feb 4, 2019 (Actual)
Last update posted
Apr 14, 2022

2018 – 2019

United States locations

U.S. sites
43
U.S. states
23
U.S. cities
39
Facility City State ZIP Site status
Vanguard Study Site Birmingham Alabama 35235 —
Vanguard Study Site Birmingham Alabama 35242 —
Vanguard Study Site Pelham Alabama 35124 —
Vanguard Study Site Hot Springs Arkansas 71913 —
Vanguard Study Site Anaheim California 92805 —
Vanguard Study Site Westminster California 92683 —
Vanguard Study Site Wilmington California 90744 —
Vanguard Study Site Miami Florida 33145 —
Vanguard Study Site Miami Florida 33155 —
Vanguard Study Site Miami Florida 33174 —
Vanguard Study Site Orlando Florida 32819 —
Vanguard Study Site Tampa Florida 33609 —
Vanguard Study Site Stockbridge Georgia 30281 —
Vanguard Study Site Blackfoot Idaho 83221 —
Vanguard Study Site Meridian Idaho 83642 —
Vanguard Study Site Nampa Idaho 83686 —
Vanguard Study Site Evanston Illinois 60201 —
Vanguard Study Site Valparaiso Indiana 46383 —
Vanguard Study Site Louisville Kentucky 40207 —
Vanguard Study Site New Orleans Louisiana 70115 —
Vanguard Study Site New Orleans Louisiana 70124 —
Vanguard Study Site Baltimore Maryland 21236 —
Vanguard Study Site St Louis Missouri 63141 —
Vanguard Study Site Missoula Montana 59808 —
Vanguard Study Site Bellevue Nebraska 68005 —
Vanguard Study Site Las Vegas Nevada 89104 —
Vanguard Study Site Brooklyn New York 11229 —
Vanguard Study Site Raleigh North Carolina 27607 —
Vanguard Study Site Cincinnati Ohio 45215 —
Vanguard Study Site Cleveland Ohio 44122 —
Vanguard Study Site Columbus Ohio 43214 —
Vanguard Study Site Dayton Ohio 45424 —
Vanguard Study Site Medford Oregon 97504 —
Vanguard Study Site East Providence Rhode Island 02914 —
Vanguard Study Site Jackson Tennessee 38305 —
Vanguard Study Site Milan Tennessee 38328 —
Vanguard Study Site Austin Texas 78735 —
Vanguard Study Site Carrollton Texas 75010 —
Vanguard Study Site Houston Texas 77058 —
Vanguard Study Site McAllen Texas 78504 —
Vanguard Study Site Plano Texas 75024 —
Vanguard Study Site Bountiful Utah 84010 —
Vanguard Study Site St. George Utah 84790 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03605862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2022 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03605862 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →